Majority of top Acthar Gel prescribers received manufacturer payments

Among rheumatologists, nephrologists and neurologists who issued more than 10 prescriptions for corticotropin in 2015, 88% received payments from its manufacturer — with more than 20% receiving more than $10,000 — despite the drug’s considerable cost and the dearth of evidence in support of its use, according to findings published in JAMA Network Open.
“Expensive therapies with uncertain or insufficient evidence supporting their use should be particularly scrutinized,” Daniel M. Hartung, PharmD, MPH, of the Oregon Health and Science University College of Pharmacy,